1. Home
  2. HTH vs SRPT Comparison

HTH vs SRPT Comparison

Compare HTH & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hilltop Holdings Inc.

HTH

Hilltop Holdings Inc.

HOLD

Current Price

$36.89

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$21.81

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTH
SRPT
Founded
1998
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.4B
IPO Year
2004
1997

Fundamental Metrics

Financial Performance
Metric
HTH
SRPT
Price
$36.89
$21.81
Analyst Decision
Hold
Hold
Analyst Count
2
28
Target Price
$34.00
$25.68
AVG Volume (30 Days)
216.6K
2.7M
Earning Date
01-29-2026
02-25-2026
Dividend Yield
1.95%
N/A
EPS Growth
53.28
N/A
EPS
2.50
N/A
Revenue
$1,259,399,000.00
$2,413,715,000.00
Revenue This Year
N/A
$13.99
Revenue Next Year
$1.64
N/A
P/E Ratio
$14.75
N/A
Revenue Growth
7.66
47.15
52 Week Low
$27.35
$10.42
52 Week High
$37.04
$120.05

Technical Indicators

Market Signals
Indicator
HTH
SRPT
Relative Strength Index (RSI) 69.65 49.28
Support Level $35.18 $20.10
Resistance Level $35.93 $21.88
Average True Range (ATR) 0.70 1.38
MACD 0.20 -0.16
Stochastic Oscillator 85.99 34.08

Price Performance

Historical Comparison
HTH
SRPT

About HTH Hilltop Holdings Inc.

Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: